| Name | Title | Contact Details |
|---|
ARC Devices is a wireless, non-contact, vital signs and medical devices monitor innovator. Founded in 2012 we create world class vital signs monitors and medical devices for clinical professionals as well as responsible consumers; ensuring that you recieve the latest benefits of the personal health-care revolution. With an ever increasing awareness of health care becoming an essential element of modern life we take pride in our reputation for excellence and originality, maintaining the highest industry standards in both our products and our consumer service. By focusing on creativity, imagination, and invention we push the boundaries of technology to meet your needs in an increasingly fast paced, health concious, world. From family friendly, non-contact thermometers, to futuristic vital signs monitors, we create easy-to-use precision instruments which are small enough to fit in the palm of your hand. As the global medical revolution gains pace the team at Arc Designs continues to innovate and take the first leaps towards the next generation of personalized healthcare. We believe in a better future and so we look to the stars to improve the ground on which you stand.
Portal Instruments is transforming the delivery of modern medicines and enhancing the standard of care for chronic diseases. Portal`s unique platform technology is capable of injecting today`s new biological drugs, regardless of volume or viscosity, with minimal sensation and time, providing the patient with enabling connectivity to optimize their disease challenges. The computer-controlled delivery technology is silent, innocuous, and highly customizable across a large variety of medical, animal, agricultural, and cosmetic applications.
Gereonics is a Solana Beach, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ultimate Wireforms is a Bristol, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ValenTx was founded with the goal of treating some of the most pervasive health problems of our time: obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension. Our approach is to create a non-surgical, endoluminal bypass device that builds on the success of established medical interventions, resulting in a highly effective and least-invasive therapy. Current treatments for these diseases include surgery, pharmacology, and medically supervised lifestyle management. The risks, costs, and in some cases poor efficacy of these treatments have hampered their broad adoption by patients, physicians, and payers alike. A truly unmet clinical need exists for a therapy that can deliver the efficacy obtained through surgery, but without the risks and costs associated with surgical intervention. The ValenTx endoluminal bypass therapy mimics the attributes of a Roux-en-Y gastric bypass and is implanted through a non-surgical, endoscopic procedure. This procedure does not require gastric stapling or permanent changes to the patient`s anatomy. The device is removable, replaceable and designed so that the physician could change the therapeutic profile, thereby optimizing the treatment towards the individual patient`s needs. ValenTx has developed a strong intellectual property portfolio, which lies at the foundation of this therapy. The company has successfully conducted a series of clinical studies demonstrating the viability, safety, and efficacy of the therapy.